                         SEQUENCE LISTING

<110>  The Trustees of the University of Pennsylvania
       Epstein, Jonathan
       Aghajanian, Haig
 
<120>  Compositions and Methods for Treating Heart Disease via 
       Redirected T Cell Immunotherapies

<130>  046483-7182WO1(01726)

<150>  US 62/563,323
<151>  2017-09-26

<160>  5     

<170>  PatentIn version 3.5

<210>  1
<211>  1482
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  FAP-CAR

<400>  1
atggccctgc ctgtgacagc cctgctgctg cctctggctc tgctgctgca tgccgctaga       60

cctggatccc aggtgcagct gaaagagtcc ggcggaggac tggtgcagcc tggcggatct      120

ctgaagctga gctgtgctgc cagcggcttc accttcagca gctacggcat gagctgggtg      180

cgacagaccg ccgacaagag actggaactg gtggctacca ccaacaacaa cggcggcgtg      240

acctactacc ccgacagcgt gaagggcaga ttcaccatct ccagagacaa cgccaagaac      300

accctgtacc tgcagatgag cagcctgcag agcgaggaca ccgccatgta ctactgcgcc      360

agatacggct actacgccat ggattactgg ggccagggca tcagcgtgac cgtgtctagc      420

ggaggcggcg gatctggcgg agggggatct agtggcggag gctctgacgt gctgatgacc      480

cagacacctc tgagcctgcc agtgtccctg ggcgaccagg ccagcatcag ctgtagaagc      540

agccagagca tcgtgcacag caacggcaac acctacctgg aatggtatct gcagaagccc      600

ggccagagcc ccaagctgct gatctacaag gtgtccaaca gattcagcgg cgtgcccgac      660

agattctccg gcagcggctc tggcaccgac ttcaccgtga agatctccag ggtggaagcc      720

gaggacctgg gcgtgtacta ctgttttcaa ggcagccacg tgccctacac cttcggcgga      780

ggcaccaagc tggaaatcaa ggctagctcc ggaaccacga cgccagcgcc gcgaccacca      840

acaccggcgc ccaccatcgc gtcgcagccc ctgtccctgc gcccagaggc gtgccggcca      900

gcggcggggg gcgcagtgca cacgaggggg ctggacttcg cctgtgatat ctacatctgg      960

gcgcccttgg ccgggacttg tggggtcctt ctcctgtcac tggttatcac cctttactgc     1020

aaacggggca gaaagaaact cctgtatata ttcaaacaac catttatgag accagtacaa     1080

actactcaag aggaagatgg ctgtagctgc cgatttccag aagaagaaga aggaggatgt     1140

gaactgagag tgaagttcag caggagcgca gacgcccccg cgtacaagca gggccagaac     1200

cagctctata acgagctcaa tctaggacga agagaggagt acgatgtttt ggacaagaga     1260

cgtggccggg accctgagat ggggggaaag ccgagaagga agaaccctca ggaaggcctg     1320

tacaatgaac tgcagaaaga taagatggcg gaggcctaca gtgagattgg gatgaaaggc     1380

gagcgccgga ggggcaaggg gcacgatggc ctttaccagg gtctcagtac agccaccaag     1440

gacacctacg acgcccttca catgcaggcc ctgccccctc gc                        1482


<210>  2
<211>  732
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Anti-mFAP scFv

<400>  2
caggtgcagc tgaaagagtc cggcggagga ctggtgcagc ctggcggatc tctgaagctg       60

agctgtgctg ccagcggctt caccttcagc agctacggca tgagctgggt gcgacagacc      120

gccgacaaga gactggaact ggtggctacc accaacaaca acggcggcgt gacctactac      180

cccgacagcg tgaagggcag attcaccatc tccagagaca acgccaagaa caccctgtac      240

ctgcagatga gcagcctgca gagcgaggac accgccatgt actactgcgc cagatacggc      300

tactacgcca tggattactg gggccagggc atcagcgtga ccgtgtctag cggaggcggc      360

ggatctggcg gagggggatc tagtggcgga ggctctgacg tgctgatgac ccagacacct      420

ctgagcctgc cagtgtccct gggcgaccag gccagcatca gctgtagaag cagccagagc      480

atcgtgcaca gcaacggcaa cacctacctg gaatggtatc tgcagaagcc cggccagagc      540

cccaagctgc tgatctacaa ggtgtccaac agattcagcg gcgtgcccga cagattctcc      600

ggcagcggct ctggcaccga cttcaccgtg aagatctcca gggtggaagc cgaggacctg      660

ggcgtgtact actgttttca aggcagccac gtgccctaca ccttcggcgg aggcaccaag      720

ctggaaatca ag                                                          732


<210>  3
<211>  72
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  CD8a transmembrane domain

<400>  3
atctacatct gggcgccctt ggccgggact tgtggggtcc ttctcctgtc actggttatc       60

accctttact gc                                                           72


<210>  4
<211>  126
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  4-1BB intracellular domain

<400>  4
aaacggggca gaaagaaact cctgtatata ttcaaacaac catttatgag accagtacaa       60

actactcaag aggaagatgg ctgtagctgc cgatttccag aagaagaaga aggaggatgt      120

gaactg                                                                 126


<210>  5
<211>  336
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  CD3-zeta signaling domain

<400>  5
agagtgaagt tcagcaggag cgcagacgcc cccgcgtaca agcagggcca gaaccagctc       60

tataacgagc tcaatctagg acgaagagag gagtacgatg ttttggacaa gagacgtggc      120

cgggaccctg agatgggggg aaagccgaga aggaagaacc ctcaggaagg cctgtacaat      180

gaactgcaga aagataagat ggcggaggcc tacagtgaga ttgggatgaa aggcgagcgc      240

cggaggggca aggggcacga tggcctttac cagggtctca gtacagccac caaggacacc      300

tacgacgccc ttcacatgca ggccctgccc cctcgc                                336


